PLx Pharma Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €7.07M +26,873.4% -€44.34M +240.7% -626.9% +490 pp -€27.67M +164.5% -391.3% +400 pp
    €26.22K -94.6% -€13.01M -29.2% -49,631.9% -460 pp -€10.46M -2.2% -39,900.1% -380 pp
    €487.17K -24.9% -€18.38M -2,480.3% -3,773.7% -39 pp -€10.70M +40.4% -2,195.9% -10 pp
    €648.84K -3.3% €772.36K -105.8% 119.0% +21 pp -€7.62M -30.7% -1,174.4% +4.7 pp
    €670.85K +∞% -€13.22M -28.0% -1,970.9% -20 pp -€11.00M -18.1% -1,639.9% -16 pp
    €0.00 +NaN% -€18.37M +13.8% N/A -€13.43M +6.8% N/A
    €0.00 +NaN% -€16.15M +38.0% N/A -€12.57M +29.4% N/A
    €0.00 +NaN% -€11.70M +238.4% N/A -€9.72M +413.9% N/A
    €0.00 +NaN% -€3.46M +117.7% N/A -€1.89M +42.1% N/A
    €0.00 -€1.59M N/A -€1.33M N/A

    Notifications